CL
Colgate-Palmolive Company
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 84.26
Buy <=wait / entry
USD 80.00
Trim >=take some off
USD 92.00
Thesis breakThe thesis would break if Colgate-Palmolive cuts or withdraws its long-term EPS ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 29% | 100 / 100 | 29.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 21% | 10 / 100 | 2.1 |
| Weighted conviction | 62 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 FY26 revenue rose to US$5,361 million from US$5,110 million with EPS beat at +0.99 versus estimate +0.95
- Full-year 2026 guidance reaffirmed for 2% to 6% net sales growth and double-digit GAAP EPS growth despite margin pressures
- Net income and earnings per share eased amid ongoing cost and margin pressures across key regions